Emerging Trends in Heart Valve Engineering: Part II. Novel and Standard Technologies for Aortic Valve Replacement

Annals of Biomedical Engineering

Volumn 43, Issue 4, 2015, Pages 844-857

  Kheradvar, Arash ^a,b   Groves, Elliott M ^a,b   Goergen, Craig J ^c   Alavi, S Hamed ^a   Tranquillo, Robert ^d   Simmons, Craig A ^e,f   Dasi, Lakshmi P ^g   Grande Allen, K Jane ^h   Mofrad, Mohammad R K ⁱ   Falahatpisheh, Ahmad ^a   Griffith, Boyce ^j,k   Baaijens, Frank ^l   Little, Stephen H ^m   Canic, Suncica ⁿ  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PURDUE UNIVERSITY   (United States)

^d University of Minnesota   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g Department of Mechanical Engineering   (United States)

^h Rice University   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j The University of North Carolina at Chapel Hill   (United States)

^k UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^l EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^m HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

ⁿ University of Houston   (United States)

more..

Author keywords

Bioprosthetic heart valves; Heart valve engineering; Mechanical heart valve; Transcatheter aortic valves

Indexed keywords

BLOOD VESSELS; DISEASES; HEART; HEART VALVE PROSTHESES; PATIENT TREATMENT;

BIOPROSTHETIC HEART VALVES; HEART VALVE DISEASE; HEART VALVE REPLACEMENT; HEART VALVES; INVASIVE TREATMENT; MECHANICAL HEART VALVES; STANDARD TECHNOLOGY; TRANSCATHETER AORTIC VALVES;

VALVES (MECHANICAL);

AORTA STENOSIS; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; BIOMEDICAL ENGINEERING; EQUIPMENT DESIGN; HANCOCK VALVE PROSTHESIS; HEART VALVE BIOPROSTHESIS; HEART VALVE PROSTHESIS; HUMAN; MECHANICAL HEART VALVE; NONHUMAN; PERCUTANEOUS AORTIC VALVE; PERICARDIAL PATCH; PRIORITY JOURNAL; REVIEW; SELF EXPANDING NITINOL STENT; STARR EDWARDS VALVE PROSTHESIS; TRANSCATHETER AORTIC VALVE IMPLANTATION; ANIMAL; AORTA VALVE; BIOPROSTHESIS; PROCEDURES; TISSUE ENGINEERING; TRENDS;

ANIMALS; AORTIC VALVE; BIOPROSTHESIS; HEART VALVE PROSTHESIS; HUMANS; TISSUE ENGINEERING;

EID: 84926153417     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-014-1191-5     Document Type: Review

References (94)

1. Alavi, S. H., E. M. Groves, and A. Kheradvar. The effects of transcatheter valve crimping on pericardial leaflets. Ann. Thorac. Surg. 97:1260–1266, 2014.
2. Alemu, Y., G. Girdhar, M. Xenos, J. Sheriff, J. Jesty, S. Einav, and D. Bluestein. Design optimization of a mechanical heart valve for reducing valve thrombogenicity-a case study with ats valve. ASAIO J. 56:389–396, 2010.
3. Amahzoune, B., P. Bruneval, B. Allam, A. Lafont, J.-N. Fabiani, and R. Zegdi. Traumatic leaflet injury during the use of percutaneous valves: a comparative study of balloon- and self-expandable valved stents. Eur. J. Cardio Thorac. Surg. 43:488–493, 2013.
4. Aupart, M. R., A. Mirza, Y. A. Meurisse, A. L. Sirinelli, P. H. Neville, and M. A. Marchand. Perimount pericardial bioprosthesis for aortic calcified stenosis: 18-year experience with 1133 patients. J. Heart Valve Dis. 15:768–775, 2006; (discussion 775-766).
5. Bach, D. S., T. David, M. Yacoub, J. Pepper, B. Goldman, J. Wood, E. Verrier, M. Petracek, V. Aldrete, and M. Rosenbloom. Hemodynamics and left ventricular mass regression following implantation of the toronto SPV stentless porcine valve. Am. J. Cardiol. 82:1214–1219, 1998.
6. Bach, D. S., M. P. Sakwa, M. Goldbach, M. R. Petracek, R. W. Emery, and F. W. Mohr. Hemodynamics and early clinical performance of the st. Jude medical regent mechanical aortic valve. Ann. Thorac. Surg. 74:2003–2009, 2002.
7. Bach, D. S., N. D. Kon, J. G. Dumesnil, C. F. Sintek, and D. B. Doty. Ten-year outcome after aortic valve replacement with the freestyle stentless bioprosthesis. Ann. Thorac. Surg. 80:480–487, 2005.
8. Benson, A. M., K. Omrane, E. M. Graves, A. L. Haas, E. Bryant, M. Mandalaywala, and A. Mueller. Synthesis of a low thrombogenic heart valve coating with horseradish peroxidase. Polym. Adv. Technol. 16:117–122, 2005.
9. Blais, C., J. G. Dumesnil, R. Baillot, S. Simard, D. Doyle, and P. Pibarot. Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation 108:983–988, 2003.
10. Borger, M. A., J. Ivanov, S. Armstrong, D. Christie-Hrybinsky, C. M. Feindel, and T. E. David. Twenty-year results of the hancock ii bioprosthesis. J. Heart Valve Dis. 15:49–56, 2006.
11. Borger, M. A., A. F. Nette, M. Maganti, and C. M. Feindel. Carpentier-edwards perimount magna valve versus medtronic hancock ii: a matched hemodynamic comparison. Ann. Thorac. Surg. 83:2054–2058, 2007.
12. Bottio, T., L. Caprili, D. Casarotto, and G. Gerosa. Small aortic annulus: the hydrodynamic performances of 5 commercially available bileaflet mechanical valves. J. Thorac. Cardiovasc. Surg. 128:457–462, 2004.
13. Bradley, S. M. Aortic valve insufficiency in the teenager and young adult: the role of prosthetic valve replacement. World J. Pediatr. Congenit. Heart Surg. 4:397–402, 2013.
14. Bruschi, G., De Marco, F., Martinelli, L., Klugmann, S. Corevalve® transcatheter self-expandable aortic bioprosthesis. 2013.
15. Carabello, B. A., and W. J. Paulus. Aortic stenosis. Lancet 373:956–966, 2009.
16. Carrier, M., M. Pellerin, A. Basmadjian, D. Bouchard, L. P. Perrault, R. Cartier, P. Page, P. Demers, and Y. Hébert. Fifteen years of clinical and echocardiographic follow up with the carbomedics heart valve. J. Heart Valve Dis. 15:67, 2006.
17. Celiento, M., L. Filaferro, A. D. Milano, G. Anastasio, G. Ferrari, U. Bortolotti. Single center experience with the sorin bicarbon prosthesis: A 17-year clinical follow-up. J. Thorac. Cardiovas. Surg. 2013.
18. Chambers, J. B., J. L. Pomar, C. A. Mestres, and G. M. Palatianos. Clinical event rates with the on-x bileaflet mechanical heart valve: a multicenter experience with follow-up to 12 years. J. Thorac. Cardiovasc. Surg. 145:420–424, 2013.
19. Cheema, F. H., N. Hussain, A. P. Kossar, and G. Polvani. Patents and heart valve surgery—i: mechanical valves. Recent Pat. Cardiovasc. Drug Discov. 8:17–34, 2013.
20. Convelbo, C., P. Guetat, M. Cambillau, B. Allam, P. Bruneval, A. Lafont, and R. Zegdi. Crimping and deployment of balloon-expandable valved stents are responsible for the increase in the hydraulic conductance of leaflets. Eur. J. Cardio Thorac. Surg. 44:1045–1050, 2013.
21. Cox, J. L., N. Ad, K. Myers, M. Gharib, and R. Quijano. Tubular heart valves: a new tissue prosthesis design—preclinical evaluation of the 3f aortic bioprosthesis. J. Thorac. Cardiovasc. Surg. 130:520–527, 2005.
22. Cunanan, C. M., C. M. Cabiling, T. T. Dinh, S. Shen, P. Tran-Hata, J. H. Rutledge, III, and M. C. Fishbein. Tissue characterization and calcification potential of commercial bioprosthetic heart valves. Ann. Thorac. Surg. 71:S417–S421, 2001.
23. Dasi, L. P., H. A. Simon, P. Sucosky, and A. P. Yoganathan. Fluid mechanics of artificial heart valves. Clin. Exp. Pharmacol. Physiol. 36:225–237, 2009.
24. de Buhr, W., S. Pfeifer, J. Slotta-Huspenina, E. Wintermantel, G. Lutter, and W. A. Goetz. Impairment of pericardial leaflet structure from balloon-expanded valved stents. J. Thorac. Cardiovasc. Surg. 143:1417–1421, 2012.
25. Dell’Aquila, A. M., D. Schlarb, S. R. Schneider, J. R. Sindermann, A. Hoffmeier, G. Kaleschke, S. Martens, and A. Rukosujew. Clinical and echocardiographic outcomes after implantation of the trifecta aortic bioprosthesis: an initial single-centre experience. Interact. Cardiovasc. Thorac. Surg. 16:112–115, 2013.
26. Desai, N. D., O. Merin, G. N. Cohen, J. Herman, S. Mobilos, J. Y. Sever, S. E. Fremes, B. S. Goldman, and G. T. Christakis. Long-term results of aortic valve replacement with the st. Jude toronto stentless porcine valve. Ann. Thorac. Surg. 78:2076–2083, 2004.
27. Emery, R. W., G. J. Van Nooten, and P. J. Tesar. The initial experience with the ATS medical mechanical cardiac valve prosthesis. Ann. Thorac. Surg. 75:444–452, 2003.
28. Emery, R. W., C. C. Krogh, D. J. Jones, D. M. Nicoloff, D. P. Blake, and K. V. Arom. A five-year follow up of the ATS mechanical heart valve. J. Heart Valve Dis. 13:231–238, 2004.
29. Falahapisheh, A., and A. Kheradvar. High-speed particle image velocimetry to assess cardiac fluid dynamics in vitro: from performance to validation. Eur. J. Mech. B/Fluids 35:2–8, 2012.
30. Fallon, A. M., L. P. Dasi, U. M. Marzec, S. R. Hanson, and A. P. Yoganathan. Procoagulant properties of flow fields in stenotic and expansive orifices. Ann. Biomed. Eng. 36:1–13, 2008.
31. Fish R. D., D. Paniagua, Ureña P, Chevalier B. The colibri heart valve: Theory and practice in the achievement of a low-profile, pre-mounted, pre-packaged TAVI valve. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 9:S111, 2013.
32. Fisher, J. Comparative study of the hydrodynamic function of six size 19 mm bileaflet heart valves. Eur. J. Cardio Thorac. Surg. 9:692–696, 1995.
33. Flameng, W., F. Rega, M. Vercalsteren, P. Herijgers, and B. Meuris. Antimineralization treatment and patient-prosthesis mismatch are major determinants of the onset and incidence of structural valve degeneration in bioprosthetic heart valves. J. Thorac. Cardiovasc. Surg. 147:1219–1224, 2014.
34. Forleo, M., and L. P. Dasi. Effect of hypertension on the closing dynamics and lagrangian blood damage index measure of the b-datum regurgitant jet in a bileaflet mechanical heart valve. Ann. Biomed. Eng. 42:110–122, 2014.
35. Gallegos, R. P., A. L. Rivard, P. T. Suwan, S. Black, S. Bertog, U. Steinseifer, A. Armien, M. Lahti, and R. W. Bianco. In-vivo experience with the triflo trileaflet mechanical heart valve. J Heart Valve Dis. 15:791–799, 2006.
36. Goldhaber, S. Z. “Bridging” and mechanical heart valves: perils, promises, and predictions. Circulation 113:470–472, 2006.
37. Gooley, R., P. Antonis, and I. T. Meredith. The next era of transcatheter aortic valve replacement: a case illustrating the benefit of a fully re-positionable, re-sheathable, and retrievable prosthesis. Catheter. Cardiovasc. Interv. 83:831–835, 2014.
38. Groves, E. M., A. Falahatpisheh, J. L. Su, and A. Kheradvar. The effects of positioning of transcatheter aortic valve on the fluid dynamics of the aortic root. ASAIO J. 60(5):545–552, 2014.
39. Grube, E., J.-M. Sinning, and A. Vahanian. The year in cardiology 2013: valvular heart disease (focus on catheter-based interventions). Eur. Heart J. 35:490–495, 2014.
40. Haussig, S., G. Schuler, and A. Linke. Worldwide tavi registries: What have we learned? Clin. Res. Cardiol. 2:1–10, 2014.
41. Holzhey, D., A. Linke, H. Treede, S. Baldus, S. Bleiziffer, A. Wagner, J. Börgermann, W. Scholtz, J.-L. Vanoverschelde, and V. Falk. Intermediate follow-up results from the multicenter engager european pivotal trial. Ann. Thorac. Surg. 96:2095–2100, 2013.
42. Ielasi, A., A. Latib, and M. Tespili. Current and new-generation transcatheter aortic valve devices: an update on emerging technologies. Expert Rev. Cardiovasc. Ther. 11:1393–1405, 2013.
43. Jin, X. Y., C. Ratnatunga, and R. Pillai. Performance of edwards prima stentless aortic valve over eight years. Sem. Thorac. Cardiovasc. Surg. 13:163–167, 2001.
44. Jun, B. H., N. Saikrishnan, and A. P. Yoganathan. Micro particle image velocimetry measurements of steady diastolic leakage flow in the hinge of a st. Jude medical((r)) regent mechanical heart valve. Ann. Biomed. Eng. 42:526–540, 2014.
45. Kaufmann, T. A., T. Linde, E. Cuenca-Navalon, C. Schmitz, M. Hormes, T. Schmitz-Rode, and U. Steinseifer. Transient, three-dimensional flow field simulation through a mechanical, trileaflet heart valve prosthesis. ASAIO J. 57:278–282, 2011.
46. Kelly, S., P. Verdonck, J. Vierendeels, K. Riemslagh, E. Dick, and G. Van Nooten. A three-dimensional analysis of flow in the pivot regions of an ATS bileaflet valve. Int. J. Artif. Org. 22:754–763, 1999.
47. Kempfert, J., H. Treede, A. J. Rastan, M. Schönburg, M. Thielmann, S. Sorg, F.-W. Mohr, and T. Walther. Transapical aortic valve implantation using a new self-expandable bioprosthesis (acurate ta™): 6-month outcomes. Eur. J. Cardio Thorac. Surg. 43:52–57, 2013.
48. Khawaja, M. Z., R. Rajani, A. Cook, A. Khavandi, A. Moynagh, S. Chowdhary, M. S. Spence, S. Brown, S. Q. Khan, N. Walker, U. Trivedi, N. Hutchinson, A. J. De Belder, N. Moat, D. J. Blackman, R. D. Levy, G. Manoharan, D. Roberts, S. S. Khogali, P. Crean, S. J. Brecker, A. Baumbach, M. Mullen, J.-C. Laborde, and D. Hildick-Smith. Permanent pacemaker insertion after corevalve transcatheter aortic valve implantation: incidence and contributing factors (the uk corevalve collaborative). Circulation 123:951–960, 2011.
49. Kheradvar, A., H. Houle, G. Pedrizzetti, G. Tonti, T. Belcik, and M. Ashraf. Lindner, J.R., Gharib, M., Sahn, D. Echocardiographic particle image velocimetry: a novel technique for quantification of left ventricular blood vorticity pattern. J. Am. Soc. Echocardiogr. 23:3102–3111, 2010.
50. Kiefer, P., F. Gruenwald, J. Kempfert, H. Aupperle, J. Seeburger, F. W. Mohr, and T. Walther. Crimping may affect the durability of transcatheter valves: an experimental analysis. Ann. Thorac. Surg. 92:155–160, 2011.
51. King, M., T. David, and J. Fisher. An initial parametric study on fluid flow through bileaflet mechanical heart valves using computational fluid dynamics. Proc. Inst. Mech. Eng. Part H 208:63–72, 1994.
52. Kodali, S. K., M. R. Williams, C. R. Smith, L. G. Svensson, J. G. Webb, R. R. Makkar, G. P. Fontana, T. M. Dewey, V. H. Thourani, and A. D. Pichard. Two-year outcomes after transcatheter or surgical aortic-valve replacement. New Engl. J. Med. 366:1686–1695, 2012.
53. Leon, M. B., C. R. Smith, M. Mack, D. C. Miller, J. W. Moses, L. G. Svensson, E. M. Tuzcu, J. G. Webb, G. P. Fontana, and R. R. Makkar. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New Engl. J. Med. 363:1597–1607, 2010.
54. Levy, F., E. Donal, L. Bière, C. Szymanski, J. P. Remadi, E. Flécher, O. Fouquet, A. Leguerrier, and C. Tribouilloy. Hemodynamic performance during exercise of the new st. Jude trifecta aortic bioprosthesis: results from a french multicenter study. J. Am. Soc. Echocardiogr. 27:590–597, 2014.
55. Marchand, M. A., M. R. Aupart, R. Norton, I. R. Goldsmith, L. C. Pelletier, M. Pellerin, T. Dubiel, W. J. Daenen, P. Herijgers, and F. P. Casselman. Fifteen-year experience with the mitral carpentier-edwards perimount pericardial bioprosthesis. Ann. Thorac. Surg. 71:S236–S239, 2001.
56. Matthews, A. M. The development of the starr-edwards heart valve. Texas Heart Inst. J. 25:282–293, 1998.
57. Miraldi, F., L. Spagnesi, D. Tallarico, G. Di Matteo, and G. Brancaccio. Sorin stentless pericardial valve versus carpentier–edwards perimount pericardial bioprosthesis: is it worthwhile to struggle? Int. J. Cardiol. 118:253–255, 2007.
58. Mohammadi, S., D. Kalavrouziotis, P. Voisine, E. Dumont, D. Doyle, J. Perron, and F. Dagenais. Bioprosthetic valve durability after stentless aortic valve replacement: the effect of implantation technique. Ann. Thorac. Surg. 97:2011–2018, 2014.
59. Naidoo, R., B. Pearse, P. Tesar, S. Yap, A. Barnett, and T. Fayers. Long-term outcomes following medtronic open pivot valved conduit. J Heart Valve Dis. 23:105–111, 2014.
60. Nishimura, R. A., C. M. Otto, R. O. Bonow, B. A. Carabello, J. P. Erwin, R. A. Guyton, P. T. O’Gara, C. E. Ruiz, N. J. Skubas, and P. Sorajja. AHA/ACC guideline for the management of patients with valvular heart disease: a report of the american college of cardiology/american heart association task force on practice guidelines. J. Am. Coll. Cardiol. 63:e57–e185, 2014.
61. Northrup, 3rd, W. F., R. W. Emery, D. M. Nicoloff, T. J. Lillehei, A. R. Holter, and D. P. Blake. Opposite trends in coronary artery and valve surgery in a large multisurgeon practice, 1979–1999. Ann. Thorac. Surg. 77:488–495, 2004.
62. Offstad, J., K. Andersen, P. Paulsson, J. Andreasson, U. Kjellman, O. Lundblad, K. G. Engstrøm, R. Haaverstad, and J. L. Svennevig. The scandinavian multicenter hemodynamic evaluation of the SJM regent aortic valve. J. Cardiothorac. Surg. 6:163, 2011.
63. Piazza, N., and J. Gregoire. Images in clinical medicines. Starr-edwards heart valves. New Engl. J. Med. 358:e24, 2008.
64. Pibarot, P., and J. G. Dumesnil. Prosthetic heart valves selection of the optimal prosthesis and long-term management. Circulation 119:1034–1048, 2009.
65. Pillai, R., C. Ratnatunga, J. L. Soon, H. Kattach, A. Khalil, and X. Y. Jin. 3f prosthesis aortic cusp replacement: implantation technique and early results. Asian Cardiovasc. Thorac. Ann. 18:13–16, 2010.
66. Prifti, E., M. Bonacchi, A. Baboci, K. Krakulli, and G. Giunti. Early and mid-term functional and hemodynamic evaluation of the st. Jude medical regent 17 mm aortic valve mechanical prosthesis. J. Heart Valve Dis. 23:112–121, 2014.
67. Puskas, J., M. Gerdisch, D. Nichols, R. Quinn, C. Anderson, B. Rhenman, L. Fermin, M. McGrath, B. Kong, and C. Hughes. Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-x valve anticoagulation clinical trial randomized food and drug administration investigational device exemption trial. J. Thorac. Cardiovasc. Surg. 147(1202–1211):e1202, 2014.
68. Rahimtoola, S. H. Choice of prosthetic heart valve in adults an update. J. Am. Coll. Cardiol. 55:2413–2426, 2010.
69. Reyes, G., S. Badia, P. Alvarez, C. Kallmeyer, S. Rodriguez, A. Sarraj, and J. Bustamante. Results of aortic valve replacement with the supra-annular sorin bicarbon overline prosthesis. J. Heart Valve Dis. 21:358–363, 2012.
70. Riess, F.-C., R. Bader, E. Cramer, L. Hansen, B. Kleijnen, G. Wahl, J. Wallrath, S. Winkel, and N. Bleese. Hemodynamic performance of the medtronic mosaic porcine bioprosthesis up to ten years. Ann. Thorac. Surg. 83:1310–1318, 2007.
71. Riess, F.-C., E. Cramer, L. Hansen, S. Schiffelers, G. Wahl, J. Wallrath, S. Winkel, and P. Kremer. Clinical results of the medtronic mosaic porcine bioprosthesis up to 13 years. Eur. J. Cardio Thorac. Surg. 37:145–153, 2010.
72. Ross, Jr., J., and E. Braunwald. Aortic stenosis. Circulation 38:61–67, 1968.
73. Rudolph, T. K., and S. Baldus, Jenavalve-transfemoral technology. EuroIntervention: Journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 9:S101, 2013.
74. Sato, M., H. Harasaki, K. E. Wika, M. V. Soloviev, and A. S. Lee. Blood compatibility of a newly developed trileaflet mechanical heart valve. ASAIO J. 49:117–122, 2003.
75. Schoen, F. J., and R. J. Levy. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann. Thorac. Surg. 79:1072–1080, 2005.
76. Schofer, J., A. Colombo, S. Klugmann, J. Fajadet, F. DeMarco, D. Tchétché, F. Maisano, G. Bruschi, A. Latib, and K. Bijuklic. Prospective multicenter evaluation of the direct flow medical® transcatheter aortic valve. J. Am. Coll. Cardiol. 63:763–768, 2014.
77. Schwarz, F., P. Baumann, J. Manthey, M. Hoffmann, G. Schuler, H. C. Mehmel, W. Schmitz, and W. Kubler. The effect of aortic valve replacement on survival. Circulation 66:1105–1110, 1982.
78. Shipkowitz, T., J. Ambrus, J. Kurk, and K. Wickramasinghe. Evaluation technique for bileaflet mechanical valves. J. Heart Valve Dis. 11:275–282, 2002.
79. Smith, C. R., M. B. Leon, M. J. Mack, D. C. Miller, J. W. Moses, L. G. Svensson, E. M. Tuzcu, J. G. Webb, G. P. Fontana, and R. R. Makkar. Transcatheter versus surgical aortic-valve replacement in high-risk patients. New Engl. J. Med. 364:2187–2198, 2011.
80. Valfrè, C., P. Ius, G. Minniti, L. Salvador, T. Bottio, F. Cesari, G. Rizzoli, and G. Gerosa. The fate of hancock ii porcine valve recipients 25 years after implant. Eur. J. Cardio Thorac. Surg. 38:141–146, 2010.
81. Van Nooten, G. J., F. Caes, K. Francois, Y. Van Belleghem, T. Bové, G. Vandenplas, M. De Pauw, and Y. Taeymans. Fifteen years’ single-center experience with the ATS bileaflet valve. J. Heart Valve Dis. 18:445–452, 2009.
82. Van Nooten, G. J., T. Bové, Y. Van Belleghem, K. François, F. Caes, G. Vandenplas, M. De Pauw, and Y. Taeymans. Twenty-year single-center experience with the medtronic open pivot mechanical heart valve. Ann. Thorac. Surg. 97:1306–1313, 2014.
83. Vavuranakis, M., D. Vrachatis, and C. Stefanadis. Corevalve aortic bioprosthesisrepositioning techniques. JACC Cardiovasc. Interv. 3:565–565, 2010.
84. Wang, J., H. Yao, C. Lim, Y. Zhao, T. Yeo, and N. Hwang. Computational fluid dynamics study of a protruded-hinge bileaflet mechanical heart valve. J. Heart Valve Dis. 10:254–262, 2001; (discussion 263).
85. Webb, J., and A. Cribier. Percutaneous transarterial aortic valve implantation: what do we know? Eur. Heart J. 32:140–147, 2011.
86. Wendt, D., M. Thielmann, T. Buck, R.-A. Jánosi, T. Bossert, N. Pizanis, M. Kamler, and H. Jakob. First clinical experience and 1-year follow-up with the sutureless 3f-enable aortic valve prosthesis. Eur. J. Cardio Thorac. Surg. 33:542–547, 2008.
87. Willson, A. B., J. Rodès-Cabau, D. A. Wood, J. Leipsic, A. Cheung, S. Toggweiler, R. K. Binder, M. Freeman, R. DeLarochellière, and R. Moss. Transcatheter aortic valve replacement with the st. Jude medical portico valvefirst-in-human experience. J. Am. Coll. Cardiol. 60:581–586, 2012.
88. Wu, J., B. M. Yun, A. M. Fallon, S. R. Hanson, C. K. Aidun, and A. P. Yoganathan. Numerical investigation of the effects of channel geometry on platelet activation and blood damage. Ann. Biomed. Eng. 39:897–910, 2011.
89. Xenos, M., G. Girdhar, Y. Alemu, J. Jesty, M. Slepian, S. Einav, and D. Bluestein. Device thrombogenicity emulator (DTE)—design optimization methodology for cardiovascular devices: a study in two bileaflet mhv designs. J. Biomech. 43:2400–2409, 2010.
90. Yankah, C. A., M. Pasic, M. Musci, J. Stein, C. Detschades, H. Siniawski, and R. Hetzer. Aortic valve replacement with the mitroflow pericardial bioprosthesis: durability results up to 21 years. J. Thorac. Cardiovasc. Surg. 136:688–696, 2008.
91. Yin, W., E. C. Ngwe, and D. A. Rubenstein. A biocompatible flow chamber to study the hemodynamic performance of prosthetic heart valves. ASAIO J. 58:470–480, 2012.
92. Yun, B. M., J. Wu, H. A. Simon, S. Arjunon, F. Sotiropoulos, C. K. Aidun, and A. P. Yoganathan. A numerical investigation of blood damage in the hinge area of aortic bileaflet mechanical heart valves during the leakage phase. Ann. Biomed. Eng. 40:1468–1485, 2012.
93. Zegdi, R., P. Bruneval, D. Blanchard, and J.-N. Fabiani. Evidence of leaflet injury during percutaneous aortic valve deployment. Eur. J. Cardio Thorac. Surg. 40:257–260, 2011.
94. Zingg, U., B. Aeschbacher, C. Seiler, U. Althaus, and T. Carrel. Early experience with the new masters series of st. Jude medical heart valve: in vivo hemodynamic and clinical results in patients with narrowed aortic annulus. J. Heart Valve Dis. 6:535–541, 1997.